サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402539

中南米の点眼薬市場、2030年までの予測：地域別分析 - タイプ別、用途別、購入方法別

South & Central America Eye Drops Market Forecast to 2030 - Regional Analysis - by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application, and Purchase Mode (OTC and Prescription)
出版日: | 発行: The Insight Partners | ページ情報: 英文 78 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
中南米の点眼薬市場、2030年までの予測：地域別分析 - タイプ別、用途別、購入方法別
出版日: 2023年11月07日
発行: The Insight Partners
ページ情報: 英文 78 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の点眼薬市場は、2022年の10億1,709万米ドルから2030年には14億3,920万米ドルに成長すると予測されています。2022年から2030年までのCAGRは4.4%と推定されます。

アイケアへの取り組みの高まりが中南米の点眼薬市場を後押し

近年、眼病に対する意識向上や啓蒙のために様々な取り組みが行われ、患者が適切な薬や治療を受けられるようになっています。例えば、TeleOftalmoはブラジルのプロジェクトで、国民の診断へのアクセスを改善するために遠隔医療眼科サービスを提供しています。また、一般の人々が眼科医療を受けられるようにするためのプロジェクトを立ち上げている製薬会社もあります。例えば、バイエルは地方政府と協力し、大都市から農村地域まで、ブラジル全土の様々な場所で治療へのアクセスを向上させ、新しい眼科医療センターを開発しました。さらに、アルゼンチンのROPプロジェクトは、保健省の母子保健プログラムが主導する統合的な眼科医療イニシアティブの成功例であり、保健・法制度全体で効果的に確立されています。このような眼科医療への取り組みは、点眼薬市場のプレーヤーに成長機会を提供する可能性が高いです。

中南米の点眼薬市場概要

南米・中米の点眼薬市場は、ブラジル、アルゼンチン、その他南米に区分されます。この地域ではブラジルが大きなシェアを占めています。また、予測期間中に最も高いCAGRを記録すると予測されています。ドライアイ疾患の有病率の上昇と、その治療における点眼薬の利点に関する意識の高まり、さらにヘルスケア施設の開拓が、中南米における点眼薬市場の急成長に寄与しています。ブラジルは中南米最大の人口を擁する国です。同国では様々な眼科学会が開催され、この専門分野での様々な技術の探求が奨励されているため、中南米の点眼薬市場にとって大きな可能性を秘めています。ドライアイの原因を解明するために様々な研究が行われています。2020年、ブラジルの高齢者人口は3,010万人で、総人口の14.3%を占めています。ブラジル地域統計院（IBGE）の推計（2019年）によると、総人口の増加率が0.2％であるのに対し、高齢者人口は年率3.6％で増加します。その結果、高齢者人口は2060年までに7,340万人に達し、これは全人口の32.2％に相当します。これらの統計は、加齢に関連する眼科疾患の発生率が上昇する可能性があり、中南米の点眼薬市場に大きなビジネスチャンスがあることを示しています。

中南米の点眼薬市場の収益と2030年までの予測（金額）

中南米の点眼薬市場セグメンテーション

中南米の点眼薬市場は、タイプ、用途、購入形態、国別に細分化されます。

タイプ別では、中南米の点眼薬市場は抗生物質、人工涙液、ホルモン剤、その他に区分されます。2022年の中南米の点眼薬市場では、抗生物質セグメントが最大シェアを占めています。

用途別では、中南米の点眼薬市場は眼病、アイケア、その他に区分されます。2022年の中南米の点眼薬市場では、眼疾患分野が最大のシェアを占めています。眼疾患セグメントはさらにドライアイ、緑内障、白内障、その他に区分されます。

購入形態に基づき、中南米の点眼薬市場はOTCと処方箋に区分されます。2022年の中南米の点眼薬市場では、処方箋セグメントが大きなシェアを占めています。

国別では、中南米の点眼薬市場はブラジル、アルゼンチン、その他南米に区分されます。2022年の中南米の点眼薬市場はブラジルが独占しています。

AbbVie Inc、Alcon AG、Bausch &Lomb Inc、Pfizer Inc、Rohto Pharmaceutical Co Ltdなどが中南米の点眼薬市場で事業を展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の点眼薬市場情勢

  • 概観
  • PEST分析
    • 中南米のPEST分析
  • パイプライン分析

第5章 南米・中南米の点眼薬市場：主要産業力学

  • 市場促進要因
    • 眼科疾患の有病率の上昇
    • 加齢に伴う眼疾患の高い発生率
  • 市場抑制要因
    • 製品回収
  • 市場機会
    • アイケアへの取り組みの高まり
  • 今後の動向
    • ライフスタイルの変化
  • 影響分析

第6章 点眼薬市場：中南米市場分析

  • 中南米の点眼薬市場売上高、2022年～2030年

第7章 中南米の点眼薬市場-収益と2030年までの予測：タイプ別

  • 抗生物質
  • 人工涙液
  • ホルモン剤
  • その他

第8章 中南米の点眼薬市場-収益と2030年までの予測：用途別

  • 眼疾患
  • アイケア
  • その他

第9章 中南米の点眼薬市場-収益と2030年までの予測：購入方法別

  • 処方薬
  • 一般用医薬品

第10章 中南米の点眼薬市場-収益と2030年までの予測：国別分析

第11章 中南米の点眼薬市場：業界情勢

  • 点眼薬市場における成長戦略（%）
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • Alcon AG
  • Pfizer Inc
  • Rohto Pharmaceutical Co Ltd
  • AbbVie Inc
  • Bausch & Lomb Inc

第13章 付録

図表

List Of Tables

List of Tables

  • Table 1. South & Central America Eye Drops Market Segmentation
  • Table 2. Brazil: South & Central America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil: South & Central America Eye Drops Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil: South & Central America Eye Drops Market, for Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Brazil: South & Central America Eye Drops Market, By Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Argentina: South & Central America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina: South & Central America Eye Drops Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Argentina: South & Central America Eye Drops Market, for Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Argentina: South & Central America Eye Drops Market, By Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Rest of South & Central America: South & Central America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Rest of South & Central America: South & Central America Eye Drops Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Rest of South & Central America: South & Central America Eye Drops Market, for Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Rest of South & Central America: South & Central America Eye Drops Market, By Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Organic Developments in the Eye Drop Market
  • Table 15. Inorganic Developments in the Eye drop Market
  • Table 16. Glossary of Terms, South & Central America Eye Drops Market

List Of Figures

List of Figures

  • Figure 1. South & Central America Eye Drops Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. Pipeline Analysis
  • Figure 4. South & Central America Eye Drops Market: Key Industry Dynamics
  • Figure 5. South & Central America Eye Drops Market: Impact Analysis of Drivers and Restraints
  • Figure 6. South & Central America Eye Drops Market Revenue (US$ Mn), 2020 - 2030
  • Figure 7. South & Central America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 8. Antibiotics: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Artificial Tears: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Hormones: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. South & Central America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 13. Eye Diseases: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Dry Eye: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Glaucoma: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cataract: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Eye Care: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. South & Central America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
  • Figure 21. Prescription: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. OTC: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. South & Central America Eye Drops Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 24. South & Central America Eye Drops Market Share by Country - 2022 & 2030, (%)
  • Figure 25. Brazil: South & Central America Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 26. Argentina: South & Central America Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Rest of South & Central America: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Growth Strategies in the Eye Drop Market (%)
目次
Product Code: BMIRE00029072

The South & Central America eye drops market is expected to grow from US$ 1,017.09 million in 2022 to US$ 1,439.20 million by 2030. It is estimated to grow at a CAGR of 4.4% from 2022 to 2030.

Rising Initiatives for Eye Care Fuels South & Central America Eye Drops Market

In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. For instance, TeleOftalmo is a Brazilian project that offers telemedicine ophthalmology services to improve population access to diagnosis. Also, some pharmaceutical companies are launching projects to provide the general population with access to eye care. For example, Bayer collaborated with the local government to increase access to treatment and develop new eye care centers in a variety of places throughout Brazil, from large cities to rural communities. Furthermore, Argentina's ROP project is an example of a successful integrated eye care initiative led by the Ministry of Health's mother and child health program that has been effectively established throughout the health and legal systems. Such initiatives for eye care will likely offer growth opportunities to the eye drop market players.

South & Central America Eye Drops Market Overview

The South & Central America eye drops market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil accounts for a major share of the market in this region. Moreover, it is projected to record the highest CAGR during the forecast period. The rising prevalence of dry eye disease and growing awareness about the benefits of eye drops for its treatment, coupled with developing healthcare facilities, contributes to the rapid growth of the South & Central America eye drops market in South & Central America. Brazil is the largest country in South & Central America, with a vast population. It holds significant potential for the South & Central America eye drops market as various conferences are held in the country for ophthalmology, which encourages exploring different technologies in this specialty. Various studies have been conducted to understand the causes of dry eye conditions. In 2020, Brazil had 30.1 million of the elderly population, representing ~14.3% of the total population. According to the Brazilian Institute of Geography and Statistics (IBGE) estimates (2019), the geriatric population would grow at a rate of 3.6% per year, compared to the 0.2% increase in the total population. As a result, the elderly population would reach 73.4 million by 2060, which will be equivalent to 32.2% of the overall population. These stats indicate significant opportunities for the South & Central America eye drops market with the possible rise in the incidence of age-related ophthalmic diseases.

South & Central America Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Eye Drops Market Segmentation

The South & Central America eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the South & Central America eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the South & Central America eye drops market in 2022.

Based on application, the South & Central America eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the South & Central America eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the South & Central America eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the South & Central America eye drops market in 2022.

Based on country, the South & Central America eye drops market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America eye drops market in 2022.

AbbVie Inc, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, and Rohto Pharmaceutical Co Ltd are some of the leading companies operating in the South & Central America eye drops market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Eye Drops Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

Table of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Eye Drops Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis
  • 4.3 Pipeline Analysis

5. South & Central America Eye Drops Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Ophthalmic Diseases
    • 5.1.2 High Incidence of Age-Related Eye Diseases
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
  • 5.3 Market Opportunities
    • 5.3.1 Rising Initiatives for Eye Care
  • 5.4 Future Trends
    • 5.4.1 Changing Lifestyle
  • 5.5 Impact Analysis

6. Eye Drops Market - South & Central Market Analysis

  • 6.1 South & Central America Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Eye Drops Market - Revenue and Forecast to 2030 - by Type

  • 7.1 Overview
  • 7.2 South & Central America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Artificial Tears
    • 7.4.1 Overview
    • 7.4.2 Artificial Tears: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Hormones
    • 7.5.1 Overview
    • 7.5.2 Hormones: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Eye Drops Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 South & Central America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Eye Diseases
    • 8.3.1 Overview
    • 8.3.2 Eye Diseases: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 Dry Eye
        • 8.3.2.1.1 Overview
      • 8.3.2.2 Dry Eye: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.3 Glaucoma
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Glaucoma: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.4 Cataract
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Cataract: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.5 Others
        • 8.3.2.5.1 Overview
        • 8.3.2.5.2 Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Eye Care
    • 8.4.1 Overview
    • 8.4.2 Eye Care: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

  • 9.1 Overview
  • 9.2 South & Central America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
  • 9.3 Prescription
    • 9.3.1 Overview
    • 9.3.2 Prescription: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 OTC
    • 9.4.1 Overview
    • 9.4.2 OTC: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 South & Central America Eye Drops Market
    • 10.1.1 Overview
    • 10.1.2 South & Central America Eye Drops Market Share by Country - 2022 & 2030, (%)
      • 10.1.2.1 Brazil: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
      • 10.1.2.2 Brazil: South & Central America Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
        • 10.1.2.2.1 Brazil: South & Central America Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.2.2 Brazil: South & Central America Eye Drops Market, By Application, 2020-2030 (US$ Million)
        • 10.1.2.2.2.1 Brazil: South & Central America Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.3 Brazil: South & Central America Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.2.3 Argentina: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
      • 10.1.2.4 Argentina: South & Central America Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
        • 10.1.2.4.1 Argentina: South & Central America Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.4.2 Argentina: South & Central America Eye Drops Market, By Application, 2020-2030 (US$ Million)
        • 10.1.2.4.2.1 Argentina: South & Central America Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.2.4.3 Argentina: South & Central America Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.2.5 Rest of South & Central America: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.5.1 Overview
      • 10.1.2.6 Rest of South & Central America: South & Central America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.6.1 Rest of South & Central America: South & Central America Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.6.2 Rest of South & Central America: South & Central America Eye Drops Market, By Application, 2020-2030 (US$ Million)
        • 10.1.2.6.2.1 Rest of South & Central America: South & Central America Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.2.6.3 Rest of South & Central America: South & Central America Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)

11. South & Central America Eye Drops Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Eye Drop Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Alcon AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pfizer Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Rohto Pharmaceutical Co Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 AbbVie Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Bausch & Lomb Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms